Clinical Trial Update: Pulmonary and Systemic Hepatocyte Growth Factors in Patients With COPD

View source ↗

Summary

A completed clinical trial evaluating pulmonary and systemic hepatocyte growth factor therapy in patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Hepatocyte Growth Factor (hepatocyte growth factor)

Snippet

Sponsor: Hospital Universitari Son Dureta | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED